 |
인쇄하기
취소
|
Hanmi to launch a modified new anti-obesity drug.
Hanmi is now ready to launch a modified new anti-obesity drug called Slimmer capsule containing sibutramine mesilate after the KFDA approval at the early of July.
Slimmer will be the first modified new anti-obesity drug developed purely by the Korean researchers by putting about 4.2 billion won of investment during the past 5 years, which was also designated as an ATC, an outstanding manuf...
Slimmer will be the first modified new anti-obesity drug developed purely by the Korean researchers by putting about 4.2 billion won of investment during the past 5 years, which was also designated as an ATC, an outstanding manuf...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.